"Global Value Chains in ASEAN: Textiles and Clothing" issued by AJC (Graphic: Business Wire) TOKYO, March 31 (Bernama-BUSINESS WIRE) -- Textiles and clothing1 are archetypal industries through which ASEAN member states achieve industrialization and integration into the global economy, according to Global Value Chains in ASEAN: Textiles and Clothing (https://www.asean.or.jp/en/centre-wide-info/gvc_database_paper14/) published by the ASEAN-Japan Centre. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200331005288/en/ It is essential to recognize the significant intra-industry variation in terms of technological attributes and factor intensity. For ASEAN, the most vibrant is clothing, which is often a major exporter, generating significant employment. Cambodia, Indonesia, Myanmar and Viet Nam are the world’s major exporters of clothing. Textiles, in contrast, play a less salient role in its overall export structure because of their technology and capital intensity. In the clothing industry, the lower-income ASEAN countries tend to specialize in labour-intensive activities such as cut, make and trim operations. In contrast, knowledge-intensive processes such as design and marketing are concentrated in the more advanced economies of the region. In 2017, the domestic value added in exports of textiles, clothing and leather (TCL) in ASEAN was about $51 billion, or 68 per cent of the total exports, which becomes part of the ASEAN GDP, while the foreign value added was the remaining balance of about $24 billion, or 32 per cent. Process and product upgrading occur primarily through technological transfer from lead firms (buyers) in global value chains. However, functional upgrading is typically achieved through local and regional markets. Failures to realize functional upgrading would leave enterprises in these industries with no option other than to apply a “race to the bottom” strategy. At the macro-level, this failure is among the root causes of the “middle-income trap.” Local and regional markets are key to prevent this result and to achieve sustainable industrial development. Policies to promote the TCL industry in ASEAN should carefully take into account the differences of each of the member countries, particularly with respect to the dynamics of international comparative advantage, which primarily stem from differences in technological and resource endowments. Promoting further regional integration will expand and deepen intraregional networks of production and distribution. To promote inclusiveness, efforts to upgrade the skills of the labour force will be crucial. A refocusing on the ASEAN regional market would prove fruitful for sustained industrial upgrading. 1 This industry often includes “leather.” Thus, statistical data on textiles and clothing refers to textiles, clothing and leather. ˂˂ASEAN-Japan Centre˃˃ The ASEAN-Japan Centre is an intergovernmental organization established by the ASEAN Member States and Japan in 1981. It has been promoting exports from ASEAN to Japan while revitalizing investment, tourism as well as people-to-people exchanges between the ASEAN Member States and Japan. URL: https://www.asean.or.jp/en/ View source version on businesswire.com: https://www.businesswire.com/news/home/20200331005288/en/ Contact ASEAN-Japan Centre Tomoko Miyauchi E-mail: [email protected] Source : ASEAN-Japan Centre
0 Comments
TOKYO, March 30 (Bernama-BUSINESS WIRE) -- Toshiba Electronic Devices & Storage Corporation (“Toshiba”) has added 80V N-channel power MOSFETs to its “U-MOS X-H series” fabricated with the latest generation process. The new MOSFETs are suitable for switching power supplies in industrial equipment used in data centers and communication base stations.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200329005003/en/ The expanded line-up includes "TPH2R408QM," housed in SOP Advance, a surface-mount type packaging, and "TPN19008QM," housed in a TSON Advance package. Shipments starts today. Drain-source On-resistance in the new 80V U-MOS X-H products, manufactured with the latest generation process, is approximately 40% lower than that of 80V products in the current generation process U-MOS VIII-H series products. The trade-off between the drain-source On-resistance and the gate charge characteristics[1] has also been improved[2] by optimizing device structure. As a result, the new products feature industry’s lowest[3] power dissipation. Toshiba is expanding its lineup of products that reduce power dissipation to help cut equipment power consumption. http://mrem.bernama.com/viewsm.php?idm=37061 KUALA LUMPUR, March 30 (Bernama) -- The legal industry is quickly adapting to new work procedures to adhere to evolving COVID-19 prevention measures while continuing to get work done.
To assist in this process, Epiq has mobilised rapidly to create a secure and legally defensible remote document review and project management solution to meet this need, according to a statement. Epiq’s remote review solution transforms legal workflows by providing a highly secure, scalable and flexible remote review programme. The programme, available globally since March 20, allows for access to any eDiscovery, incident response or contracts review platform. The solution allows Epiq to rapidly scale up teams of reviewers across locations, in a highly agile way, to respond to the needs of clients. Using an array of oversight options, including comprehensive reporting metrics, confidentiality agreements and training, Epiq has successfully created a global, digital team of expert managers for all review matters. The solution is carefully built to ensure secure remote work by using multi-factor authentication and verified https protocols and includes a complete set of safety measures ranging from disabled data redirection to automated data clearing on virtual desktops. The remote solution will continue to be available to clients and will evolve over time to provide more features, functionality and security. No longer limited by facility space or location, the remote review platform at Epiq reaches clients anywhere, anytime. More details at https://www.epiqglobal.com. -- BERNAMA Conagen develops unprecedented critical lactoferrin protein produced via fermentation worldwide
Bedford, Mass., March 25 (Bernama-GLOBE NEWSWIRE) -- Conagen announced today the discovery and development of a sustainable proprietary lactoferrin protein that mirrors the nutritional properties of lactoferrin from breast milk. The first-of-its-kind natural lactoferrin protein is produced via fermentation process at commercial-scale. Mother’s milk is the best nutrition because it is the ideal way to bind and deliver iron for infant nutrition, but it is not sourceable at large-scale. Yet, lactoferrin is necessary as it plays an important role in the newborn immune system and contributes to healthy infant digestion and nutrition. Lactoferrin found in cow’s milk has been useful for producing certain specialized infant formula in many countries, but its performance is not optimal as it takes more time for the protein to bind with iron than breast milk and it is not sustainable. The nutritional needs of an infant could be even better met with proteins that more closely match those in breast milk, like Conagen’s lactoferrin. Another supporting factor for Conagen’s lactoferrin is an increased consumer awareness of nutritional benefits in food, which is carrying over to the global infant formula market. As a result, manufacturers are embarking on designing formulations that closely replicate the composition of breast milk. To meet both consumers’ demands and manufacturers’ quests, Conagen produced a lactoferrin by advanced fermentation for the use in infant formula and other nutritional products that can now be fortified naturally and sustainably worldwide. “Nourishing the world’s children is a priority for infant formula manufacturers. We want to support them for providing a lactoferrin as similar to breast milk lactoferrin as is possible with a low cost sourceable solution,” said Vice President of Research and Development, Casey Lippmeier. Conagen’s lactoferrin will give infant formula manufacturers a more scalable, sustainable, and lower cost-in-use solutions than sourcing from cow’s milk. In anticipation of FDA GRAS, manufacturers can begin testing the proprietary ingredient in the formulation processes. The powerful protein may also be used in pharmaceutical and dietary supplement applications too. Consumer demand for infant nutrition products is growing and is expected to reach a global market value of $103 billion by 2026. In 2018, the global infant formula market size was valued at approximately $45 billion. For more than half a century, infant formula has remained static until now when consumers are becoming more food and nutrition conscious. The protein was first isolated from cow’s milk in 1939. Twenty years later, it was recognized as the main iron binding protein in breast milk, although different forms of lactoferrin are found both in cow’s milk and breast. “The time has arrived to take a closer look at nutrition because it is such a critical part of our lives and the future of our children. Conagen is advancing in this space by developing functional and sustainable ingredients for improved human development and reduced environmental impact,” said Lippmeier. Crucial to the natural development of a newborn’s immune system, lactoferrin is linked to linked several physiological and protective functions, including: anti-infective and anti-inflammatory activities, and as its name implies, regulation of iron absorption in the infant gut. The ingestion of lactoferrin in breast milk has a probiotic effect to the infant gastrointestinal system, which cannot be fully matched by bovine lactoferrin. About Conagen Conagen is an accomplished biotechnology company located in the greater Boston biotech corridor. We innovate and develop synthetic biology solutions for supporting global partners across a spectrum of current and developing markets. From our proprietary strain development to fermentation and scaling up, Conagen impacts partners’ abilities to sell and market products in the food, nutrition, flavor and fragrance, pharmaceutical, and renewable materials industries. Attachments Ana Arakelian Conagen +1.949.750.6812 [email protected] SOURCE: Conagen http://mrem.bernama.com/viewsm.php?idm=37027 KAGOSHIMA, Japan, Mar. 25, 2020 /Kyodo JBN-AsiaNet/ --
Kagoshima City now presents a music video in several foreign languages for overseas viewers to commemorate the City's 130th anniversary. The music video has been released on YouTube to promote the City's new theme song "Kagoshima into the Future", and attractions of the City. YouTube URL: https://www.youtube.com/watch?v=pX2rzPTonD8 *English/Chinese (traditional & simplified)/Korean/Thai/Vietnamese subtitles are available. (Photo1: https://kyodonewsprwire.jp/prwfile/release/M100580/202003198267/_prw_PI1lg_It8j4Qk0.png) (Photo2: https://kyodonewsprwire.jp/prwfile/release/M100580/202003198267/_prw_PI2fl_QMH0hj1V.png) Kagoshima City's theme song, "Kagoshima into the Future" This song, released in November 2019, portrays some of the great points that showcase Kagoshima City starting with the symbols of Kagoshima, the active volcano Sakurajima and the scenic and tranquil Kinko Bay. It conveys the abundant nature of the City, the strength that spurred the modernization of Japan, and the splendor the City offers to international tourists. The music video shows the City's beautiful sceneries, starting with Sakurajima volcano, and highlights many attractions of the City. Composer & Arranger: Ryo Yoshimata (born in Kagoshima City): https://kyodonewsprwire.jp/img/202003198267-O3-UJJQ0XKx An introduction to Kagoshima City Kagoshima City is located at the southern end of Kyushu Island in Japan. It is a unique place where approximately 600,000 people are living with the active volcano Sakurajima, which towers above the downtown area across Kagoshima Bay (Kinko Bay). The City is called "the Naples of the Orient" as the volcano view from the City resembles that of its sister city Naples, Italy. (Image: https://kyodonewsprwire.jp/prwfile/release/M100580/202003198267/_prw_PI4lg_vxhPg8ww.jpg) Emblem and Statement of Kagoshima City: https://kyodonewsprwire.jp/prwfile/release/M100580/202003198267/_prw_PI5fl_bExjDwf6.jpg SOURCE: Kagoshima City KUALA LUMPUR, March 24 -- LeddarTech® recently announced the addition of four executives to the corporation, enhancing product vision and development, manufacturing, supply chain and strategic partnerships.
According to a statement, Stéphane Rousseau has been appointed vice-president of Global Operations, overseeing manufacturing, production engineering, project management, quality & standard conformity, IT and Supply Chain. Dr David Cheskis, as the vice-president of Product Line Management, will oversee system-on-chip (SoC), software and LiDAR module product lines for automotive and mobility. Having been with LeddarTech over the past decade, Michael Poulin takes over as vice-president of Strategic Partnerships and Corporate Development. His key responsibilities entail strategic partnerships and the Leddar™ Ecosystem, as well as lead corporate strategic planning and other growth initiatives. Lastly, David Moon joins LeddarTech as director of Automotive Products within the Product Line Management team. He will manage the team for the automotive LiDAR SoC products. LeddarTech® is an industry leader in LiDAR technology, providing the most versatile and scalable auto and mobility LiDAR platform in the market. -- BERNAMA Announces Preclinical COVID-19 Research Tools
RENSSELAER, N.Y., March 23 (Bernama-GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces support for global COVID-19 research efforts via a new Coronavirus Toolkit featuring relevant models and services. Mouse models have been extensively used for research on the SARS-CoV virus, closely related to the new SARS-CoV-2 virus that causes COVID-19. Taconic offers many animal models and services to support COVID-19 research and empower the global fight against this disease. Taconic’s Coronavirus Toolkit models are grouped by application: COVID-19 disease models, antibody development and production, and vaccine research and development. The toolkit includes several proprietary models, one example being an Ace2 knockout mouse available to Taconic through our partnership with inventor Lexicon Pharmaceuticals. Ace2 knockout mice are used to study acute respiratory distress syndrome (ARDS), a COVID-19 complication. Taconic and Lexicon have partnered to scale production of this strain with subsidized distribution to researchers worldwide. A second example includes genetically humanized HLA (human leukocyte antigen) mice, which are better able to model human vaccine response compared to standard mice. Finally, Taconic is one of only a few companies in the world which can produce humanized immune system mice on scale, which carry human immune cells in a mouse. Beyond models, Taconic’s colony management solutions also offer relief to laboratories faced with restrictions, staff reductions, or temporary closures.Cryopreservation services are offered at a highly competitive price to ensure the security of valuable genetically modified models for the future. As research priorities change, Taconic also encourages researchers to consider custom model generation as a path to move research forward without requiring extensive internal human resources. Taconic has the most comprehensive, fully-licensed gene modification toolkit in the industry. "Taconic is proud to contribute to the global fight against the coronavirus pandemic. We take our mission to provide animal model solutions seriously and are committed to empowering COVID-19 research," shared Nancy J. Sandy, Taconic Biosciences’ chief executive officer. "We are investing significant resources to make these critical models available to enable immediate studies.” To learn more about Taconic Biosciences' Coronavirus Toolkit, please contact Taconic at 1-888-TACONIC (888-822-6642) in the US, +45 70 23 04 05 in Europe, or email [email protected]. About Taconic Biosciences, Inc. Taconic Biosciences is a fully-licensed, global leader in genetically engineered rodent models and services. Founded in 1952, Taconic provides the best animal solutions so that customers can acquire, custom-generate, breed, precondition, test, and distribute valuable research models worldwide. Specialists in genetically engineered mouse and rat models, microbiome, immuno-oncology mouse models, and integrated model design and breeding services, Taconic operates three service laboratories and six breeding facilities in the U.S. and Europe, maintains distributor relationships in Asia and has global shipping capabilities to provide animal models almost anywhere in the world. Media Contact: Kelly Owen Grover Director of Marketing Communications (518) 697-3824 [email protected] Source: Taconic Biosciences --BERNAMA Three-tiered, mobile-app driven program tracks individuals’ physical and psychological symptoms from COVID-19
RALEIGH, N.C., March 23 (Bernama-GLOBE NEWSWIRE) -- PRA Health Sciences announced today the commercial availability of the COVID-19 Monitoring Program, a mobile app-driven, tiered initiative that allows employers, payers, providers and health systems to track the health and wellbeing of individuals who may be asymptomatic, exposed or diagnosed with COVID-19 during the pandemic. Based on an individual’s COVID-19 disease status, they are assigned to one of three groups:
“The COVID-19 pandemic has shown the critical need for organizations of all sizes to be able to remotely assist individuals in monitoring their health and wellbeing,” said Kent Thoelke, Executive Vice President and Chief Scientific Officer at PRA Health Sciences. “Given the scale of the COVID-19 pandemic, we are about to see our healthcare system and its infrastructure significantly stretched. With this program, individuals can have the peace of mind that they can connect with a healthcare professional from the comfort of their own homes while maintaining social distancing. Having the ability to interact with individuals remotely during this uncertain time is critical to maintaining the infrastructure and capability of the healthcare system as well as safety of patients and business continuity.” The program, which was created by Care Innovations, a PRA Health Sciences company, can be deployed within days. Built on the cloud based Health Harmony Digital Health Platform, the program can also scale immediately and receive updated content as guidelines are changed. PRA is deploying the COVID-19 Monitoring Program and mobile app to healthcare organizations, large employers, and the company is in discussions with academic institutions, governmental organizations, health departments and other private businesses to roll out the program. For more information on the COVID-19 Monitoring Program, please contact Care Innovations at https://www.careinnovations.com/contact/ or by phone at 855-885-CARE. ABOUT PRA HEALTH SCIENCES PRA (NASDAQ: PRAH) is one of the world’s leading global contract research organizations by revenue, providing outsourced clinical development and data solution services to the biotechnology and pharmaceutical industries. PRA’s global clinical development platform includes more than 75 offices across North America, Europe, Asia, Latin America, South Africa, Australia and the Middle East and more than 17,500 employees worldwide. Since 2000, PRA has participated in approximately 4,000 clinical trials worldwide. In addition, PRA has participated in the pivotal or supportive trials that led to U.S. Food and Drug Administration or international regulatory approval of more than 95 drugs. INVESTOR INQUIRIES: [email protected] MEDIA INQUIRIES: Laurie Hurst, Director, Communications and Public Relations [email protected], +1.919.786.8435 SOURCE : PRA Health Sciences, Inc. Total Revenue Reaches New Peak despite the market condition,
Total Dividends Increase by 27% YoY1 HONG KONG, March 23 (Bernama-BUSINESS WIRE) -- Guotai Junan International Holdings Limited (“Guotai Junan International”, “the Group” or “the Company”, Stock code: 1788.HK) today announced its annual results for the year ended 31 December 2019 (the “Year”). Benefitting from good performance in debt capital markets, equity capital markets , brokerage, asset management, fixed income market making and investment, during the Year, the Group recorded a total revenue of HKD4,246 million approximately, achieved the historic high and increased by 40% YOY1. The profit attributable to shareholders amounted to HKD895 million, representing a YOY1 growth of approximately 12%. http://mrem.bernama.com/viewsm.php?idm=37002 KUALA LUMPUR, March 19 -- Australian local brand of probiotic yogurt, HEY YOGURT is set to open 100 shops this year, as well as similar outlets in Kuala Lumpur, Melaka and Johor in Malaysia.
In two months of intensive preparations, HEY YOGURT opened its first Asia shop in Singapore in mid-January this year, operated by Hey Yogurt Pte Ltd. According to a statement, HEY YOGURT is a brand under WK Holdings Limited, focusing on advocating for health with ‘low sugar and low fat’. It innovatively combines Australian yellow peaches, grain and yogurt to create low-temperature yogurt with natural probiotics and dietary supplement. -- BERNAMA |
Archives
April 2023
Categories |